Biotech entity
pharma is the sole category represented across all 2 tracked stories. GSK is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across a 165-day span, the pace is roughly 0.1 stories per week. They are less corroborated than the beat average, carrying 2 original sources each against 3.7 for the same window.
Last mentioned: Aug 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 2 tracked stories. GSK is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across a 165-day span, the pace is roughly 0.1 stories per week. They are less corroborated than the beat average, carrying 2 original sources each against 3.7 for the same window. The 5 average consequence score is below the beat benchmark of 6.2 in the same window. We currently track 2 Biotech stories that mention Collegium Pharmaceutical, published between February 26, 2026 and August 9, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 611 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Collegium Pharmaceutical. Shared-story counts are live from our verified record — not editorial picks.
Collegium Pharmaceutical's earnings beat of $0.20 per share, reaching $1.92 on $199.88M revenue, highlights its commercial success in the abuse-deterrent opioid space, a key sector for the biopharma industry.
Source: dailypolitical.com · themarketsdaily.com
Wave Life Sciences and Collegium Pharmaceutical reported full-year 2025 results, highlighting a transformative period for RNA editing and commercial pain management. Wave's clinical progress in AATD and DMD remains a primary valuation driver, while Collegium continues to optimize its specialized portfolio through strategic acquisitions.
Collegium Pharmaceutical is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
